Tumor Infiltrating Lymphocyte Clinical Trials in Shanghai
2 recruitingShanghai, China
Showing 1–2 of 2 trials
Recruiting
Early Phase 1
A Study of TIL in Advanced Solid Tumors (DFGD)
Advanced Solid TumorTreatment Side EffectsEffects of Immunotherapy+1 more
Shanghai Juncell Therapeutics30 enrolled1 locationNCT06488950
Recruiting
Early Phase 1
A Study of GC101 TIL in Advanced Melanoma (10hospital)
Advanced MelanomaTreatment Side EffectsEffects of Immunotherapy+1 more
Shanghai Juncell Therapeutics50 enrolled1 locationNCT05098184